NCT02872467View on ClinicalTrials.gov

Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Substance Abuse ProblemPregnancy
Interventions
DRUG

Syntocinon treatment

24 IU twice daily (A single dose will be delivered consisting of 6 intranasal insufflations (3 in each nostril) which is equivalent to a total of 24 international units (IU) of oxytocin twice daily).

OTHER

Placebo

Placebo nasal spray vials will contain the same ingredients in the nasal preparation, but without oxytocin.

Trial Locations (1)

27599-7175

UNC School of Medicine, Medical School Wing D, Chapel Hill

All Listed Sponsors
collaborator

Foundation of Hope, North Carolina

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT02872467 - Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology | Biotech Hunter | Biotech Hunter